Drug · DIN 02230302
CODEINE CONTIN 50MG CONTROLLED RELEASE TAB
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 13, 1997; first marketed March 13, 1997.
- Drug Identification Number (DIN)
- 02230302
- Company (DIN owner)
- Purdue PharmaToronto, Ontario, Canada
- Schedule
- Narcotics (CDSA I)
- Dosage form
- Tablet (Extended-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Codeine R05DA04
- Class
- Human
- Record last updated
- June 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| CODEINE (CODEINE MONOHYDRATE, CODEINE SULFATE TRIHYDRATE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 24, 1996: NOC 4275Supplement to a New Drug Submission (SNDS) · New strength